Key Market Indicators
Germany is expected to maintain vaccination coverage for children aged one year at 93% by 2028, the same rate as in 2023. This stability has been a hallmark of the German market since 1985. On the export front, German vaccine exports are projected to decline slightly. By 2028, exports are anticipated to reach approximately $578 million, down from around $581 million in 2023, marking an average annual decrease of 0.2%. Since 1996, Germany's vaccine supply has decreased by an average of 2.3% per year. In 2023, Germany ranked ninth globally in vaccine exports, with Poland slightly ahead at $581 million. Belgium, the United Kingdom, and France occupied the second, third, and fourth positions, respectively. Conversely, German vaccine imports are on the rise. Projections indicate that imports will grow to about $1.31 billion by 2028, up from approximately $1.22 billion in 2023, reflecting an average annual growth rate of 1%. Since 1996, Germany's demand for vaccines has increased by 0.6% per year.
